SPI Infoamtion

Table of Contents

Executive Summary

Industry overview
Cipla
Ranbaxy
GSK (India)
Piramal Healthcare
Zydus Cadila
Sun Pharma
Lupin Laboratories (Lupin)
Alkem
Sanofi-Aventis (India)
Mankind Pharma (Mankind)

Chapter 1 Introduction

What is this report about?
Methodology

Chapter 2 Industry overview

Summary
Introduction
Market dynamics

Indian pharmaceutical market: size and growth
Key market drivers and resistors
India's adoption of product patent regime
Evolution of biopharmaceuticals in India
Competitive positioning of India in global pharmaceutical market

Competitive landscape

Competitive positioning of the top 10 companies
Exposure to US generics market
Comparative analysis of the top 10 companies

Trends

Increasing participation of innovator companies in Indian pharmaceutical space
Pharmaceutical companies making inroads into rural India
Shifting focus towards Japanese generics market
Growing prevalence of lifestyle diseases
Expanding alliances in biopharmaceuticals

Chapter 3 Cipla

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Expanding in international markets through alliances and partnerships
Expanding capabilities
Growing in the US generics market
Acquisitions and divestments

SWOT analysis

Chapter 4 Ranbaxy

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Rebuilding business in the US market

Shifting focus towards complex products in the US
Monetizing the FTF opportunities in the US

Improving penetration in emerging markets
Strengthening management involvement in Ranbaxy
Acquisitions and divestments

SWOT analysis

Chapter 5 GSK (India)

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Augmenting product portfolio in India

Leveraging its parent company's product portfolio
In-licensing products

Expanding rural presence and hospital sales
Acquisitions and divestments

SWOT analysis

Chapter 6 Piramal Healthcare

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Capitalize on contract manufacturing opportunities
Growing business through alliances and partnerships
Acquisitions and divestments

SWOT analysis

Chapter 7 Zydus Cadila

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Alliances fostering growth in international generics markets
Sustaining revenue growth in Indian formulation business
Acquisitions and divestments

SWOT analysis

Chapter 8 Sun Pharma

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Enhancing presence in the US market
Focusing on niche segments in developing markets
Plugging gaps in its business through investments
Acquisitions and divestments

SWOT analysis

Chapter 9 Lupin

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Expanding in European markets
Foray into biosimilars market
Sustaining growth in the US generics market
Shifting focus to chronic and specialized products in India
Acquisitions and divestments

SWOT analysis

Chapter 10 Alkem

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Expanding presence in nutraceuticals business
Expansion in international markets
Acquisitions and divestments

SWOT analysis

Chapter 11 Sanofi-Aventis (India)

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Leveraging parent company's product portfolio
Shifting focus to rural India
Acquisitions and divestments

SWOT analysis

Chapter 12 Mankind

Summary
Company overview
Marketed products
Therapeutic focus
Research and development
Growth strategies

Expanding in international markets
Investing in pharmaceutical capabilities development
Foray into fast growing segments
Acquisitions and divestments

SWOT analysis

Chapter 13 11-20 companies

Abbott (India)

Company overview
Marketed products
Therapeutic focus
Research and development

Dr Reddy's

Company overview
Marketed products
Therapeutic focus
Research and development

Wockhardt

Company overview
Marketed products
Therapeutic focus
Research and development

Aristo

Company overview
Marketed products
Therapeutic focus

Torrent Pharmaceuticals (Torrent)

Company overview
Marketed products
Therapeutic focus
Research and development

Pfizer (India)

Company overview
Marketed products
Therapeutic focus
Research and development

Intas

Company overview
Marketed products
Therapeutic focus
Research and development

Alembic

Company overview
Marketed products
Therapeutic focus
Research and development

FDC

Company overview
Marketed products
Therapeutic focus
Research and development

Macleods Pharmaceuticals (Macleods)

Company overview
Marketed products
Therapeutic focus
Research and development

Chapter 14 Appendix

Glossary
Index

List of Figures
Figure 2.1: Indian pharmaceutical market size ($m), 2009-14
Figure 2.2: Key market drivers and resistors of Indian pharmaceutical market
Figure 2.3: Indian pharmaceutical market SWOT analysis
Figure 2.4: Top 10 pharmaceutical companies in India market share, 2008
Figure 2.5: Top 10 pharmaceutical companies in India growth, 2004-08
Figure 2.6: Comparative analysis of the top Indian pharmaceutical companies
Figure 2.7: Top 10 pharmaceutical companies in India lifestyle segment market share (%), 2008
Figure 3.8: Cipla therapeutic focus, 2007-08
Figure 3.9: Cipla SWOT analysis
Figure 4.10: Ranbaxy therapeutic focus, 2007-08
Figure 4.11: Ranbaxy SWOT analysis
Figure 5.12: GSK (India) therapeutic focus, 2007-08
Figure 5.13: GSK (India) SWOT analysis
Figure 6.14: Piramal Healthcare therapeutic focus, 2007-08
Figure 6.15: Piramal Healthcare SWOT analysis
Figure 7.16: Zydus Cadila therapeutic focus, 2007-08
Figure 7.17: Zydus Cadila SWOT analysis
Figure 8.18: Sun Pharma therapeutic focus, 2007-08
Figure 8.19: Sun Pharma SWOT analysis
Figure 9.20: Lupin therapeutic focus, 2007-08
Figure 9.21: Lupin SWOT analysis
Figure 10.22: Alkem therapeutic focus, 2007-08
Figure 10.23: Alkem SWOT analysis
Figure 11.24: Sanofi-Aventis (India) therapeutic focus, 2007-08
Figure 11.25: Sanofi-Aventis (India) SWOT analysis
Figure 12.26: Mankind therapeutic focus, 2007-08
Figure 12.27: Mankind SWOT analysis
Figure 13.28: Abbott (India) therapeutic focus, 2007-08
Figure 13.29: Dr Reddy's therapeutic focus, 2007-08
Figure 13.30: Wockhardt therapeutic focus, 2007-08
Figure 13.31: Aristo therapeutic focus, 2007-08
Figure 13.32: Torrent therapeutic focus, 2007-08
Figure 13.33: Pfizer (India) therapeutic focus, 2007-08
Figure 13.34: Intas therapeutic focus, 2007-08
Figure 13.35: Alembic therapeutic focus, 2007-08
Figure 13.36: FDC therapeutic focus, 2007-08
Figure 13.37: Macleods therapeutic focus, 2007-08

List of Tables
Table 2.1: Indian pharmaceutical market size ($m), 2009-14
Table 2.2: Novel product pipeline of select Indian biotechnology companies, 2008
Table 2.3: Major foreign acquisitions by Indian pharmaceutical companies, 2007-09
Table 2.4: Top 10 pharmaceutical companies in India growth (%), 2004-08
Table 2.5: Selected ANDA filings approved in the US, 2009
Table 2.6: Deals and alliances in Japanese pharmaceutical market, 2007-09
Table 2.7: Selected alliances in the Indian biopharmaceutical market, 2007-09
Table 3.8: Cipla snapshot
Table 3.9: Cipla top 10 marketed products sales ($m), 2007-08
Table 3.10: Cipla new product launches, 2007-08
Table 3.11: Approved ANDAs of Cipla in the US, 2007-09
Table 4.12: Ranbaxy snapshot
Table 4.13: Ranbaxy top 10 marketed products sales in India ($m), 2007-08
Table 4.14: Selected Ranbaxy ANDAs with FTF status
Table 4.15: Ranbaxy acquisitions, 2007-09
Table 5.16: GSK (India) snapshot
Table 5.17: GSK (India) top 10 marketed products sales ($m), 2007-08
Table 5.18: GSK (India) product launches from parent portfolio, 2007-09
Table 5.19: GSK (India) expected new launches in India, 2009-10.
Table 6.20: Piramal Healthcare snapshot
Table 6.21: Piramal Healthcare top 10 marketed products sales ($m), 2007-08
Table 6.22: Piramal Healthcare new product launches, 2007-08
Table 6.23: Select Piramal Healthcare's alliances, 2007-09
Table 6.24: Piramal Healthcare acquisitions, 2007-09
Table 7.25: Zydus Cadila snapshot
Table 7.26: Zydus Cadila top 10 marketed products sales ($m), 2007-08
Table 7.27: Zydus Cadila R&D collaborations, 2007-09
Table 7.28: Select Zydus Cadila's alliances, 2005-09
Table 7.29: Zydus Cadila acquisitions, 2007-09
Table 8.30: Sun Pharma snapshot
Table 8.31: Sun Pharma top 10 marketed products sales ($m), 2007-08
Table 8.32: Sun Pharma new product launches, 2007-08
Table 9.33: Lupin snapshot
Table 9.34: Lupin top 10 marketed products sales ($m), 2007-08
Table 9.35: Lupin acquisitions, 2007-09
Table 10.36: Alkem snapshot
Table 10.37: Alkem top 10 marketed products sales ($m), 2007-08
Table 11.38: Sanofi-Aventis (India) snapshot
Table 11.39: Sanofi-Aventis (India) top 10 marketed products sales ($m), 2007-08
Table 11.40: Sanofi-Aventis (India) key brands launches from parent portfolio
Table 12.41: Mankind snapshot
Table 12.42: Mankind top 10 marketed products sales ($m), 2007-08
Table 13.43: Abbott (India) snapshot
Table 13.44: Abbott (India) top 10 marketed products sales ($m), 2007-08
Table 13.45: Dr Reddy's snapshot
Table 13.46: Dr Reddy's top 10 marketed products sales ($m), 2007-08
Table 13.47: Dr Reddy's drug development pipeline, 2007-08
Table 13.48: Wockhardt snapshot
Table 13.49: Wockhardt top 10 marketed products sales ($m), 2007-08
Table 13.50: Aristo snapshot
Table 13.51: Aristo top 10 marketed products sales ($m), 2007-08
Table 13.52: Torrent snapshot
Table 13.53: Torrent top 10 marketed products sales ($m), 2007-08
Table 13.54: Pfizer (India) snapshot
Table 13.55: Pfizer (India) top 10 marketed products sales ($m), 2007-08
Table 13.56: Intas snapshot
Table 13.57: Intas top 10 marketed products sales ($m), 2007-08
Table 13.58: Alembic snapshot
Table 13.59: Alembic top 10 marketed products sales ($m), 2007-08
Table 13.60: FDC snapshot
Table 13.61: FDC top 10 marketed products sales ($m), 2007-08
Table 13.62: Selected FDC new product launches, 2007-08
Table 13.63: Macleods snapshot
Table 13.64: Macleods top 10 marketed products sales($m), 2007-08